Focus on knowledge creation
Without ideas there is nothing to manageMarch 2023
Participating in innovative medicines initiative funded neurodegenerative disorder projects—An impact analysis conducted as part of the NEURONET project. Hawksworth C, Salih F, Cresswell K, Steukers L, Diaz C, Killin L, Pradier L, Bradshaw A and Dawoud D. Frontiers in Neurology
Neurodegeneration Public-private partnership IMI JU
January 2023
The amyloid imaging for the prevention of Alzheimer’s disease consortium: A European collaboration with global impact. Collij LE, Farrar G, Valléz García D, Bader I, Shekari M, Lorenzini L, Pemberton H, Altomare D, Pla S, Loor M, Markiewicz P, Yaqub M, Buckley C, Frisoni GB, Nordberg A, Payoux P, Stephens A, Gismondi R, Visser PJ, Ford L, Schmidt M, Birck C, Georges J, Mett A, Walker Z, Boada M, Drzezga A, Vandenberghe R, Hanseeuw B, Jessen F, Schöll M, Ritchie C, Lopes Alves I, Gispert JD and Barkhof F, Frontiers in Neurology
Alzheimer’s disease Diagnosis Prognosis Amyloid
November 2022
Avoiding fragmentation: The potential of synergistic efforts across the IMI portfolio. Díaz C, Killin L, Hughes N. Front. Neurol. 2022; 13: 1050360.
Neurodegeneration Public-private partnership Data standardization Cohort studies Research platforms
November 2022
The Innovative Medicines Initiative neurodegeneration portfolio: From individual projects to collaborative networks. O’Rourke D, Coll-Padrós N, Bradshaw A, Killin L, Pradier L, Georges J, Dawoud DM, Steukers L and Díaz C.
Front. Neurol. – Sec. Dementia and Neurodegenerative Diseases
Neurodegeneration Public-private partnership Research policy IMI
May 2022
The value of public‐private collaborative Real‐World Evidence platforms to monitor vaccine performance post authorization: DRIVE – a European initiative. Díez‐Domingo J, Torcel‐Pagnon L, Carmona A, Launay O, Dos Santo G, Rizzo C, Haag M, Stuurman A, Nauta J, Vannacci A, de Lusignan S, del Rey E, Levi M, Lina B, Bellino S, Nye S, Neels P, Nohynek H, Mahé C. Expert Review of Vaccines Journal
Vaccination Public-private partnership Influenza
March 2022
eTRANSAFE: Building a sustainable framework to share reproducible drug safety knowledge with the public domain. Sarntivijai S, Blomberg N, Lauer KB, Briggs K, Steger-Hartmann T, van der Lei J, Caves A, Sauer JM, Liwski R, Mourby M, Camprubi M, and the eTRANSAFE Consortium. F1000Research 2022
Drug toxicity Drug safety Data sharing Data mining
March 2021
The eTRANSAFE Project on Translational Safety Assessment through Integrative Knowledge Management: Achievements and Perspectives. Pognan F, Steger‐Hartmann T, Díaz C, Blomberg N, Bringezu F, Briggs K, Callegaro G, Capella‐Gutierrez S, Centeno E, Corvi J, Drew P, Drewe WC, Fernández JM, Furlong LI, Guney E, Kors JA, Mayer MA, Pastor M, Piñero J, Ramírez‐Anguita JM, Ronzano F, Rowell P, Saüch‐Pitarch J, Valencia A, van de Water B, van der Lei J, van Mulligen E and Sanz F. Pharmaceuticals
Drug toxicity Drug safety Data sharing Knowledge
February 2021
Guidelines for FAIR Sharing of Preclinical Safety and Off‐Target Pharmacology Data*. Briggs K, Bosc N, Camara T, Díaz C, Drew P, Drewe WC, Kors J, van Mulligen E, Pastor M, Pognan F, Quintana JR, Sarntivijai S, Steger‐Hartmann T. ALTEX
Data sharing Preclinical FAIR Off-target pharmacology
November 2019
Real‐world evidence in Alzheimer’s disease: The ROADMAP Data Cube. Janssen O, Vos SJB, Garcia‐Negredo G, Tochel C, Gustavsson A, Smith M, Ly A, Nelson M, Baldwin H, Sudlow C, Bexelius C, Jindra C, Vaci N, Bauermeister S, Gallacher J, Ponjoan A, Dufoil C, Garre‐Olmo J, Pedersen L, Skoog I, Hottgenroth A, Jelle‐Visser P, van der Lei J, Díaz C. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association
Alzheimer Data sharing RWE EHR
January 2019
Challenges for Optimizing Real‐World Evidence in Alzheimer’s Disease: The ROADMAP Project. Gallacher J, de Reydet de Vulpillieres F, Amzal B, Angehrn Z, Bexelius C, Bintener C, Bouvy JC, Campo L, Diaz C, Georges J, Gray A, Hottgenroth A, Jonsson P, Mittelstadt B, Potashman MH, Reed C, Sudlow C, Thompson R, Tockhorn-Heidenreich A, Turner A, van der Lei J, Visser PJ, ROADMAP Consortium
Alzheimer’s disease Data sharing Data systems Health policy Patient Outcome assessment
April 2018
A methodology for fine‐grained access control in exposing biomedical data. Trifan A, van der Lei J, Díaz C, Oliveira JL. Studies in health technologies and informatics
Data exposure Data privacy Data sharing
October 2017
Legacy data sharing to improve drug safety assessment: the eTOX project. Sanz F, Pognan F, Steger‐Hartmann T, Díaz C, eTOX, Cases M, et al. Nature Reviews Drug Discovery
Drug toxicity Data sharing
July 2017
[P1–395]: AMYPAD: A European public-private partnership to investigate the value of β-amyloid brain scans as a diagnostic and therapeutic marker for Alzheimer’s disease. Farrar G, Barkhof F, Pla S, Gispert JD, Foley C, Mett A, Ritchie CW, Georges J, Stephens A, Schmidt ME, Van Der Geyten S, Frisoni GB.Alzheimer’s & Dementia, 13: P420-P420
Alzheimer’s Disease
May 2017
Immunization in pregnancy clinical research in low- and middle-income countries – Study design, regulatory and safety considerations . Kochhar S, Bonhoeffer J, Jones CE, Muñoz FM, Honrado A, Bauwens J, Sobanjo‐ter Meulen A, Hirschfeld S.Kochhar S, Bonhoeffer J, Jones CE, Muñoz FM, Honrado A, Bauwens J, Sobanjo‐ter Meulen A, Hirschfeld S. Vaccine
Clinical trials Vaccination Immunization Pregnancy
October 2016
Global alignment of immunization safety assessment in pregnancy – The GAIA project. Bonhoeffer J, Kochhar S, Hirschfeld S, Heath PT, Jones CE, Bauwens J, Honrado A, Heininger U, Muñoz FM, Eckert L, Steinhoff M, Black S, Padula M, Sturkenboom M, Buttery J, Pless R, Zuber P for the GAIA project
Clinical trials Vaccination Immunization Pregnancy
June 2016
Making sense of big data in health research: Towards an EU action plan. Auffray C, Balling R, Barroso I, Bencze L, Benson M, Bergeron J, et al. Genome Medicine
Big Data Health Research Medical Informatics
December 2014
Guia de gestió projectes Horizon2020 (Guide for managing Horizon 2020 projects). Honrado A, Molero E, Díaz C. ACCIÓ‐Agència per la Competitivitat de l’Empresa (Generalitat de Catalunya
European Projects Management Horizon2020
December 2013
Gathering and Exploring Scientific Knowledge in Pharmacovigilance. Lopes P, Nunes T, Campos D, Furlong LI, Bauer‐Mehren A, Sanz F, Carrascosa MC, Mestres J, Kors J, Singh B, van Mulligen E, Van der Lei J, Diallo G, Avillach P, Ahlberg E, Boyer S, Díaz C, Oliveira JL. Public Library of Science (PLOS ONE)
Pharmacovigilance ADR Data mining
December 2012
The EU‐ADR Web Platform: Delivering advanced pharmacovigilance tools. Oliveira JL, Lopes P, Nunes T, Campos D, Boyer S, Ahlberg E, van Mulligen EM, Kors JA, Singh B, Furlong LI, Sanz F, Bauer‐Mehren A, Carrascosa MC, Mestres J, Avillach P, Diallo G, Díaz C, van der Lei J. Pharmacoepidemiology and Drug Safety
Pharmacovigilance EHR ADR
May 2012
Knowledge engineering for health: a new discipline required to bridge the “ICT gap” between research and healthcare. Beck T, Gollapudi S, Brunak S, Graf N, Lemke HU, Dash D, Buchan I, Díaz C, Sanz F, Brookes AJ. Human Mutation
Knowledge engineering VPH I4Health
February 2012
Electronic healthcare databases for active drug safety surveillance: is there enough leverage? Coloma PM, Trifirò G, Schuemie MJ, Gini R, Hering R, Hippisley‐Cox J, Mazzaglia G, Picelli G, Corrao G, Pedersen L, van der Lei J, Sturkenboom M, on behalf of the EU‐ADR consortium. Pharmacoepidemiology and Drug Safety
EHR Drug safety Databases Pharmacovigilance
January 2012
Automating classification of free‐text electronic health records for epidemiological studies. Schuemie MJ, Sen E, ‘t Jong GW, van Soest EM, Sturkenboom MC, Kors JA. Pharmacoepidemiology and drug safety
EHR Machine learning Data mining
May 2011
An Informatics Project and Online ‘‘Knowledge Centre’’ Supporting Modern Genotype‐to‐phenotype research. Webb AJ, Thorisson GA, Brookes AJ, on behalf of the GEN2PHEN Consortium. Human mutation
Genotype Phenotype Computational biology
January 2011
Combining electronic healthcare databases in Europe to allow for large‐scale drug safety monitoring: the EU‐ADR Project. Coloma P, Schuemie MJ, Trifirò G, Gini R, Herings R, Hippisley‐Cox J, Mazzaglia G, Giaquinto C, Corrao G, Pedersen L, van der Lei J, Sturkenboom M, on behalf of the EU‐ADR Consortium. Pharmacoepidemiology and Drug Safety
EHR Drug safety Databases
July 2010
In silico prediction of in vivo toxicity ‐ the first steps of the e‐Tox consortium. Steger‐Hartmann T, Pognan F, Sanz F, Díaz C, Sutter A, Pastor M. Toxicology Letters
in vivo in silico Drug toxicity
March 2010
XGAP: a uniform and extensible data model and software platform for genotype and phenotype. Swertz MA, van der Velde KJ, Tesson BM, Scheltema RA, Arends D, Vera G, Alberts R, Dijkstra M, Schofield P, Schughart K, Hancock JM, Smedley D, Wolstencroft K, Goble C, de Brock EO, Jones AR, Parkinson HE, members of the Coordination of Mouse Informatics Resources (CASIMIR), Genotype‐To‐Phenotype (GEN2PHEN) Consortiums, Jansen RC. Genome Biology
Genomic Genetic Genetic Association studies Genotype Phenotype
December 2009
Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? Trifirò G, Pariente A, Coloma PM, Kors JA, Polimeni G, Miremont‐Salamé G, Catania MA, Salvo F, David A, Moore N, Caputi AP, Sturkenboom M, Molokhia M, Hippisley‐Cox J, Díaz C, van der Lei J, Fourrier‐Reglat A, EU‐ADR group.C. Pharmacoepidemiology and Drug Safety
EHR Drug toxicity Data mining
September 2009
In silico prediction of in vivo toxicities (eTox)—The Innovative Medicines Initiative Approach. Steger‐Hartmann T, Pognan F, Sanz F, Diaz C. Toxicology Letters
in vivo in silico Drug toxicity
September 2009
The EU-ADR Project: Preliminary Results and Perspective. Trifirò G, Fourrier-Reglat A, Sturkenboom MC, Díaz C, Van Der Lei J., EU-ADR Group. Studies in health technologies and informatics
EHR Drug toxicity Data mining
April 2009
Planning the Human Variome Project: The Spain Report. Kaput J, Cotton RGH, Hardman L, Al Aqeel AI, Al‐Aama JY, Al‐Mulla F, et al. Human Mutation
Genotype Phenotype Polymorphism
March 2008
Training Multidisciplinary Biomedical Informatics Students: Three Years of Experience. van Mulligen EM, Cases M, Hettne K, Molero E, Weeber M, Robertson KA, Olivia B, de la Calle G, Maojo V. Journal of the American Medical Informatics Association (JAMIA)
Medical information Data collection Education
October 2007
Education and research in INFOBIOMED, the European Network of Excellence in Biomedical. De la Calle G, van Mulligen EM, Molero E, Perez‐Rey D, Martín L, Crespo J, Maojo V. AMIA: Annual Symposium Proceedings
Medical information Education Genomics
2005
INFOBIOMED: European Network of Excellence on Biomedical Informatics to Support Individualised. Maojo V, de la Calle G, Martín‐Sánchez F, Díaz C, Sanz F. AMIA: Annual Symposium Proceedings
Medical informatics Microbiology Pilot projects
2005
The INFOBIOMED network of excellence: developments for facilitating training and mobility. De la Calle G, Benito M, Moreno JL, Molero E. Proceeding ISBMDA’05
Mobility Brokerage service Bioinformatics Statistics
January 2004
Biomedical Informatics: From Past Experiences to the Infobiomed Network of Excellence. Maojo V, Martin‐Sanchez F, Barreiro JM,Díaz C, Sanz F. Lecture Notes in Computer Science
Medical information Bioinformatics
November 2002
LINK3D: secure linking of organisations involved in distributed drug discovery. Diaz C, Blat J, González A, Herráiz C, Laurie B, Molero E, Palmer JLS, Pastor M, Patak A, Ramírez A, Sanz F, Soto D and the LINK3D Consortium. Challenges and Achievements in E‐business and E‐work
Computer simulation Drug design
November 2002
Distant collaboration in drug discovery: the LINK3D project. Pastor M, Benedetti P, Carotti A, Carrieri A, Díaz C, et al. LINK3D Consortium. Journal of computer‐aided molecular design
Computer simulation Drug design
September 2000
Information technology in community pharmacies for supporting responsible self‐medication. Sanz F, Silveira C, Díaz C, Alonso A, Loza MI, et al. American Journal of Health‐System Pharmacy
Community pharmacy Self medication Statistics
January 2000
New technologies for the marketing and sale of medicines on the Internet and television networks. Final Study. Sanz F, Gaedt K, Alonso A, Díaz C. European Parliament DG Research (Directorate A) The STOA Programme
Medical information Education Genomics Data Collection